Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers
Griffin P
GP
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology / Q000627:therapeutic use*; D011379:Prognosis; D016896:Treatment Outcome
D000986:Antisickling Agents; D006918:Hydroxyurea